Patents
Patent data provided by The
European Patent Office
and updated through early 2009. Full text patent data loaded weekly coming soon.
-
First
-
Previous
-
1
-
US5703111 (A), filed
Dec 04, 1996
, published
Dec 30, 1997
- SQUIBB BRISTOL MYERS CO
This invention relates to a stable, easy to constitute, injectable formulation of anticancer agent BMY-25067. More specifically, the present invention concerns a formulation of BMY-25067 obtained from lyophilizing a solution comprising up to 4 mg of BMY-25067...
US5760069 (A), filed
Jun 07, 1995
, published
Jun 02, 1998
- BOEHRINGER MANNHEIM PHARM CORP
A method of treatment using a compound of Formula I: IMAGE (I) wherein: R1 is hydrogen, lower alkanoyl of up to 6 carbon atoms or aroyl selected from benzoyl and naphthoyl; R2 is hydrogen, lower alkyl of up to 6 carbon atoms or arylalkyl selected from...
US6025364 (A), filed
Jan 15, 1999
, published
Feb 15, 2000
- ANORMED INC
PCT No. PCT/IB97/00688 Sec. 371 Date Jan. 15, 1999 Sec. 102(e) Date Jan. 15, 1999 PCT Filed May 15, 1997 PCT Pub. No. WO97/44030 PCT Pub. Date Nov. 27, 1997Invented is a method of treating asthma, in mammals, including humans, which comprises administering to...
US2003105138 (A1), filed
Dec 19, 2002
, published
Jun 05, 2003
- BOEHRINGER MANNHEIM PHARM CORP
A method of treatment using a compound of Formula I: wherein: R1 is hydrogen, lower alkanoyl of up to 6 carbon atoms or aroyl selected from benzoyl and naphthoyl; R2 is hydrogen, lower alkyl of up to 6 carbon atoms or arylalkyl selected from benzyl,...
US2005272799 (A1), filed
Jul 07, 2005
, published
Dec 08, 2005
- BALOG JAMES A
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
US2006004081 (A1), filed
May 19, 2005
, published
Jan 05, 2006
- MEDAREX INC
The present disclosure provides drug-cleavable substrate conjugates that are potent cytotoxins. The disclosure is also directed to compositions containing the drug-cleavable substrate conjugates, and to methods of treatment using them.
US2006020014 (A1), filed
Jul 21, 2005
, published
Jan 26, 2006
- WYETH CORP
The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and...
US2006020015 (A1), filed
Jul 21, 2005
, published
Jan 26, 2006
- WYETH CORP
The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and...
US2006100263 (A1), filed
Oct 31, 2005
, published
May 11, 2006
- STERN WARREN
Methods and compositions containing bicifadine are provided for the treatment and prevention of hyperthermia in mammalian subjects. The methods and compositions may be used to prevent or treat fever, pyresis, menopausal hot flashes; peri menopausal hot...
US2007021488 (A1), filed
Jul 20, 2006
, published
Jan 25, 2007
- WYETH CORP
The present invention is directed to compounds of formula I: where RSUP1/SUP, RSUP2/SUP, RSUP3/SUP, RSUP4/SUP, and RSUP5 /SUPare as defined herein, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia,...
US2008306132 (A1), filed
Jun 09, 2008
, published
Dec 11, 2008
- MACEDO GERRY
An improved semisolid composition for an oral veterinary application and a method of making it. A carprofen paste composition is made for orally administering to animals using calibrated syringe dispensers for exact dosages.
US5902821 (A), filed
Dec 29, 1997
, published
May 11, 1999
- BOEHRINGER MANNHEIM PHARM CORP
PCT No. PCT/EP96/00498 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Feb. 7, 1996 PCT Pub. No. WO96/24348 PCT Pub. Date Aug. 15, 1996A method of treatment using carvedilol is disclosed, wherein the carvedilol decreases the mortality...
US2006063821 (A1), filed
Sep 21, 2005
, published
Mar 23, 2006
- WYETH CORP
The invention is directed to a method of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula:
US2007082939 (A1), filed
Jul 24, 2006
, published
Apr 12, 2007
- EPSTEIN JOSEPH W
The present invention provides novel compositions and methods for treating symptoms associated with neuropathic disorders such as hyperalgesia, allodynia, and parasthesias, using a 1-aryl-3-azabicyclo[3.1.0] hexane. The invention further relates to the use of...
US2007082940 (A1), filed
Jul 25, 2006
, published
Apr 12, 2007
- EPSTEIN JOSEPH W
The invention provides novel, multiply-substituted 1-aryl-3-azabicyclo[3.1.0]hexanes, and related processes and intermediates for preparing these compounds, as well as compositions and methods employing these compounds for the treatment and/or prevention of...
